Search Results

GLP-1 metabolite GLP-1(9-36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion. ...

• Authors : Gandasi, Nikhil R; Gao, Rui; Kothegala, Lakshmi

Subjects: GLP-1; Glp1r; Glucagon

Record details

GLP-1 vasodilatation in humans with coronary artery disease is not adenosine mediated. ...

• Authors : Aetesam-Ur-Rahman, Muhammad; Giblett, Joel P; Khialani, Bharat

Subjects: Basal microvascular resistance BMR; Coronary artery disease CAD; Glucagon-like peptide 1 GLP-1

Record details

Neue Ansätze zur Regeneration der insulinproduzierenden β-Zelle

• Authors : Schlüssel, E.; Lickert, H.

Subjects: Diabetes mellitus · InsulininhibitorischerRezeptor · Antikörper · Gezielte Therapie · GLP-1

• Source: Diabetologie 18, 792–801 (2022)

Record details

The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes Uncontrolled on Metformin Alone in Denmark

• Authors : Ehlers, Lars H.; Lamotte, Mark; Ramos, Mafalda C.

Subjects: SC semaglutide; IQVIA Core Diabetes Model; GLP-1 receptor agonist

• Source: Ehlers, L H, Lamotte, M, Ramos, M C, Sandgaard, S, Holmgaard, P, Kristensen, M M & Ejskjaer, N 2022, ' The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes

Record details

The 'Early Treatment' Approach Reducing Cardiovascular Risk in Patients with Type 2 Diabetes: A Consensus From an Expert Panel Using the Delphi Technique

• Authors : Angelo Avogaro; Aldo P. Maggioni; Michele Senni ...

Subjects: medicine.medical_specialty; GLP-1 receptor agonist; Delphi method

• Source: Diabetes Therapy

Record details

Gastrointestinal Tolerability of Once-Weekly Dulaglutide 3.0 mg and 4.5 mg: A Post Hoc Analysis of the Incidence and Prevalence of Nausea, Vomiting, and Diarrhea in AWARD-11

• Authors : Heike Jung; Manige Konig; Joanna Van

Subjects: Gastrointestinal; medicine.medical_specialty; Nausea

• Source: Diabetes Therapy

Record details

Wann GLP-1-Analoga, wann SGLT-2-Hemmer verordnen?

• Authors : Baptist Gallwitz

Subjects: business.industry; Diabetes mellitus; medicine

• Source: MMW - Fortschritte der Medizin. 163:57-61

Record details

Health state utilities associated with treatment process for oral and injectable GLP-1 receptor agonists for type 2 diabetes

• Authors : Luis-Emilio Garcia-Perez; Louis S. Matza; Kirsi Norrbacka

Subjects: Male; medicine.medical_specialty; Type 2 diabetes

• Source: Quality of Life Research

Record details

The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain

• Authors : Virginia Martín; Francisco Javier Ortega; Samuel J. P. Malkin

Subjects: medicine.medical_specialty; endocrine system diseases; Cost

• Source: Diabetes Therapy

Record details

Switch-to-Semaglutide Study (STS-Study): a Retrospective Cohort Study

• Authors : Marc Y. Donath; Gottfried Rudofsky; Matthias Hepprich

Subjects: medicine.medical_specialty; Endocrinology, Diabetes and Metabolism; 030209 endocrinology & metabolism

• Source: Diabetes Therapy

Record details